Affluent Medical SAS
AFME.PA
| Exchange: | PA |
| Currency | Euro |
| ISIN: | FR0013333077 |
| Primary Ticker: | AFME.PA |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Medical Devices |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Equipment & Supplies |
| Gic Sub Industry: | Health Care Equipment |
| Description: | Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France. |
| Address: | 320, avenue Archimède, Aix-en-Provence, France, 13100 |
| Website: | https://www.affluentmedical.com |
| Full Time Employees: | 66 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 73647120 |
| Market Capitalization Mln: | 73.64 |
| EBITDA: | -14729000 |
| Wall Street Target Price: | 4 |
| Book Value: | 1.02 |
| Earnings Share: | -0.53 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -13.32 |
| Return On Assets TTM: | -0.16 |
| Return On Equity TTM: | -0.47 |
| Revenue TTM: | 1295000 |
| Revenue Per Share TTM: | 0.04 |
| Quarterly Revenue Growth YOY: | 0.12 |
| Gross Profit TTM: | -1337000 |
| Diluted Eps TTM: | -0.53 |
Valuation
| Price Sales TTM: | 56.87 |
| Price Book MRQ: | 2.33 |
| Enterprise Value: | 88824029 |
| Enterprise Value Revenue: | 1739.56 |
| Enterprise Value Ebitda: | -4.16 |
Shares
| Shares Outstanding: | 39174000 |
| Shares Float: | 5661182 |
| Percent Insiders: | 21.21 |
| Percent Institutions: | 54.03 |
Technicals
| Beta: | 0.61 |
| 52 Week High: | 2.3 |
| 52 Week Low: | 1.22 |
| 50 Day MA: | 1.81 |
| 200 Day MA: | 1.75 |
Splits & Dividends
| Last Split Factor: | 304:297 |
| Last Split Date: | 2022-08-31 |
Earnings
| Report Date: | 2023-05-02 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.37 |
| Report Date: | 2022-09-28 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.44 |
| Eps Difference: | -0.44 |
| Report Date: | 2022-04-30 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.39 |
| Eps Difference: | -0.39 |
| Report Date: | 2021-09-22 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Eps Actual: | -0.39 |
| Eps Difference: | -0.39 |
| Report Date: | 2021-04-14 |
| Date: | 2021-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | -0.4 |
| Eps Difference: | -0.4 |
| Date: | 2023-03-31 |
| Eps Actual: | -1.9 |